The neuropathogenesis of HIV encephalitis and HIV dementia is associated with sustained viral replication in brain macrophages and microglia. Viral penetration of the BBB and productive infection of brain macrophages appears necessary but not sufficient for the development of neurological abnormalities. Therefore, the hypothesis of interest is that specific viral neurotropic strains may produce qualitative changes in brain function resulting in macrophage effector molecule neurotoxin release. In addition, different strains of HIV-1 could produce qualitatively distinct central nervous system (CNS) abnormalities that affect monocyte transendothelial migration and production of toxins. To assess the role of specific HIV-1 strains in viral neuropathogenesis, the Investigator plans to study virologic, cellular immune, and functional outcomes of virus-macrophage interactions. Utilizing a blood/brain barrier system in the SCID mouse model of HIV encephalitis, he and his associates will propagate large numbers of microglia and blood monocytes to perform interactive experiments that could validate the hypothesis that different HIV-1 strains could produce distinct CNS pathological lesions. These studies will provide a rationale to address scientifically whether specific HIV-1 strains induce changes, qualitative and quantitative, in macrophage function that affect CNS neuroimmune interactions leading to progressive neurological disease in AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29AI042404-04
Application #
6170954
Study Section
AIDS and Related Research Study Section 7 (ARRG)
Program Officer
Plaeger, Susan F
Project Start
1997-08-01
Project End
2002-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
4
Fiscal Year
2000
Total Cost
$102,200
Indirect Cost
Name
University of Nebraska Medical Center
Department
Pathology
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Rom, Slava; Zuluaga-Ramirez, Viviana; Reichenbach, Nancy L et al. (2016) PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier. J Neuroinflammation 13:254
Nukuna, Adeline; Gendelman, Howard E; Limoges, Jenae et al. (2004) Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis. J Neurovirol 10 Suppl 1:82-90
Poluektova, Larisa Y; Munn, David H; Persidsky, Yuri et al. (2002) Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol 168:3941-9
Persidsky, Y; Limoges, J; Rasmussen, J et al. (2001) Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. J Neuroimmunol 114:57-68
Limoges, J; Poluektova, L; Ratanasuwan, W et al. (2001) The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis. Virology 281:21-34
Poluektova, L; Moran, T; Zelivyanskaya, M et al. (2001) The regulation of alpha chemokines during HIV-1 infection and leukocyte activation: relevance for HIV-1-associated dementia. J Neuroimmunol 120:112-28
Limoges, J; Persidsky, Y; Poluektova, L et al. (2000) Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice. Neurology 54:379-89
Persidsky, Y; Zheng, J; Miller, D et al. (2000) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68:413-22
Persidsky, Y; Ghorpade, A; Rasmussen, J et al. (1999) Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155:1599-611
Persidsky, Y (1999) Model systems for studies of leukocyte migration across the blood - brain barrier. J Neurovirol 5:579-90